Log in to save to my catalogue

Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2...

Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1898010815

Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women

About this item

Full title

Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women

Publisher

United States: Public Library of Science

Journal title

PloS one, 2017-05, Vol.12 (5), p.e0176428-e0176428

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

Subjects

Subjects and topics

More information

Scope and Contents

Contents

In the HIV-1 vaccine trial RV144, ALVAC-HIV prime with an AIDSVAX® B/E boost reduced HIV-1 acquisition by 31% at 42 months post first vaccination. The bivalent AIDSVAX® B/E vaccine contains two gp120 envelope glycoproteins, one from the subtype B HIV-1 MN isolate and one from the subtype CRF01_AE A244 isolate. Each envelope glycoprotein harbors a h...

Alternative Titles

Full title

Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1898010815

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1898010815

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0176428

How to access this item